A phase 4, 24-week, open-label study to evaluate the safety and tolerability of once-daily dosing of 75 mg rimegepant for episodic migraine prevention. [PDF]
Antinew J +7 more
europepmc +1 more source
The Second Exteroceptive Suppression Period of the Temporalis Muscle Is Altered in Migraine Patients with Allodynia. [PDF]
Rota E +6 more
europepmc +1 more source
Lifetime classic psychedelic use and headaches: A cross-sectional study. [PDF]
Bjurenfalk Z +3 more
europepmc +1 more source
Idiopathic Mediastinal Fibrosis: A Study of a Case Using CT and Bronchoscopic Imaging. [PDF]
Chaanoun K +4 more
europepmc +1 more source
Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice. [PDF]
Effinger DP +8 more
europepmc +1 more source
Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies. [PDF]
Zeng W +6 more
europepmc +1 more source
General issues arising in the use of drugs for headache disorders [PDF]
Paemeleire, Koen, Tfelt-Hansen, Peer
core +1 more source
Fibrosing Mediastinitis Caused by Histoplasmosis in an Adolescent. [PDF]
Ganigara M +8 more
europepmc +1 more source
Robust serotonin activation of the kisspeptin GnRH pulse generator in male and female mice.
Morris PG +7 more
europepmc +1 more source

